Literature DB >> 26051469

Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.

Lesya V Zelenchuk1, Anne-Marie Hedge1, Peter S N Rowe2.   

Abstract

CONTEXT: Mice with null mutations in matrix extracellular phosphoglycoprotein (MEPE) have increased bone mass, increased trabecular density and abnormal cancellous bone (MN-mice). These defects worsen with age and MEPE overexpression induces opposite effects. Also, genome wide association studies show that MEPE plays a major role in bone mass. We hypothesized that the conserved C-terminal MEPE ASARM-motif is chiefly responsible for regulating bone mass and trabecular structure.
DESIGN: To test our theory we overexpressed C-terminal ASARM-peptide in MN-mice using the Col1α1 promoter (MNAt-mice). We then compared the bone and renal phenotypes of the MNAt-mouse with the MN-mouse and the X-linked hypophosphatemic rickets mouse (HYP). The HYP mouse overexpresses ASARM-peptides and is defective for the PHEX gene.
RESULTS: The MN-mouse developed increased bone mass, bone strength and trabecular abnormalities that worsened markedly with age. Defects in bone formation were chiefly responsible with suppressed sclerostin and increased active β-catenin. Increased uric acid levels also suggested that abnormalities in purine-metabolism and a reduced fractional excretion of uric acid signaled additional renal transport changes. The MN mouse developed a worsening hyperphosphatemia and reduced FGF23 with age. An increase in the fractional excretion of phosphate (FEP) despite the hyperphosphatemia confirms an imbalance in kidney-intestinal phosphate regulation. Also, the MN mice showed an increased creatinine clearance suggesting hyperfiltration. A reversal of the MN bone-renal phenotype changes occurred with the MNAt mice including the apparent hyperfiltration. The MNAt mice also developed localized hypomineralization, hypophosphatemia and increased FGF23.
CONCLUSIONS: The C-terminal ASARM-motif plays a major role in regulating bone-mass and cancellous structure as mice age. In healthy mice, the processing and release of free ASARM-peptide are chiefly responsible for preserving normal bone and renal function. Free ASARM-peptide also affects renal mineral phosphate handling by influencing FGF23 expression. These findings have implications for understanding age-dependent osteoporosis, unraveling drug-targets and developing treatments.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASARM-peptide; FGF23; MEPE; Mineralization; Rickets; Sclerostin

Mesh:

Substances:

Year:  2015        PMID: 26051469      PMCID: PMC4501877          DOI: 10.1016/j.bone.2015.05.030

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  60 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.

Authors:  Gerald J Atkins; Peter S Rowe; Hui P Lim; Katie J Welldon; Renee Ormsby; Asiri R Wijenayaka; Lesya Zelenchuk; Andreas Evdokiou; David M Findlay
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

3.  Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

Authors:  Marcelo Campos; Constance Couture; Izaura Y Hirata; Maria A Juliano; Thomas P Loisel; Philippe Crine; Luiz Juliano; Guy Boileau; Adriana K Carmona
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass.

Authors:  Lori C Gowen; Donna N Petersen; Amy L Mansolf; Hong Qi; Jeffrey L Stock; George T Tkalcevic; Hollis A Simmons; David T Crawford; Kristen L Chidsey-Frink; Hua Zhu Ke; John D McNeish; Thomas A Brown
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

5.  MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

Authors:  P S Rowe; P A de Zoysa; R Dong; H R Wang; K E White; M J Econs; C L Oudet
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

6.  Serum uric acid is associated with bone health in older men: a cross-sectional population-based study.

Authors:  Iraj Nabipour; Philip N Sambrook; Fiona M Blyth; Margaret R Janu; Louise M Waite; Vasi Naganathan; David J Handelsman; David G Le Couteur; Robert G Cumming; Markus J Seibel
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

7.  Abnormal regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in X-linked hypophosphatemia: a translational or post-translational defect.

Authors:  Ikuma Fujiwara; Rolands Aravindan; Ron L Horst; Marc K Drezner
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

8.  Disordered regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase gene expression by phosphorus in X-linked hypophosphatemic (hyp) mice.

Authors:  Nasreen Azam; Martin Y H Zhang; Xuemei Wang; Harriet S Tenenhouse; Anthony A Portale
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

Review 9.  Histomorphometric measurements of bone turnover, mineralization, and volume.

Authors:  Susan M Ott
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

10.  Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation.

Authors:  Ming Zhao; Stephen E Harris; Diane Horn; Zhaopo Geng; Riko Nishimura; Gregory R Mundy; Di Chen
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  10 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Comprehensive phenotyping of cutaneous afferents reveals early-onset alterations in nociceptor response properties, release of CGRP, and hindpaw edema following spinal cord injury.

Authors:  Olivia C Eller; Rena N Stair; Christopher Neal; Peter S N Rowe; Jennifer Nelson-Brantley; Erin E Young; Kyle M Baumbauer
Journal:  Neurobiol Pain       Date:  2022-06-17

3.  Kidney stone formation in a novel murine model of polycystic kidney disease.

Authors:  Heather A L Riddle; Shiqin Zhang; Feng Qian; James C Williams; Jason R Stubbs; Peter Stanley N Rowe; Stephen C Parnell
Journal:  Am J Physiol Renal Physiol       Date:  2022-03-28

4.  Do ASARM peptides play a role in nephrogenic systemic fibrosis?

Authors:  Peter S N Rowe; Lesya V Zelenchuk; Jennifer S Laurence; Phil Lee; William M Brooks; Ellen T McCarthy
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02

5.  Genome-wide association reveals QTL for growth, bone and in vivo carcass traits as assessed by computed tomography in Scottish Blackface lambs.

Authors:  Oswald Matika; Valentina Riggio; Marie Anselme-Moizan; Andrew S Law; Ricardo Pong-Wong; Alan L Archibald; Stephen C Bishop
Journal:  Genet Sel Evol       Date:  2016-02-08       Impact factor: 4.297

Review 6.  The Bone Extracellular Matrix in Bone Formation and Regeneration.

Authors:  Xiao Lin; Suryaji Patil; Yong-Guang Gao; Airong Qian
Journal:  Front Pharmacol       Date:  2020-05-26       Impact factor: 5.810

7.  Comparison and Contrast of Bone and Dentin in Genetic Disorder, Morphology and Regeneration: A Review.

Authors:  Jaehyun Kim; Gayeong Lee; Woo Sung Chang; Si Hyoung Ki; Joo-Cheol Park
Journal:  J Bone Metab       Date:  2021-02-28

Review 8.  Recent advances in design and applications of biomimetic self-assembled peptide hydrogels for hard tissue regeneration.

Authors:  Haniyeh Najafi; Mahboobeh Jafari; Ghazal Farahavar; Samira Sadat Abolmaali; Negar Azarpira; Sedigheh Borandeh; Raheleh Ravanfar
Journal:  Biodes Manuf       Date:  2021-07-20

Review 9.  The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.

Authors:  Janak L Pathak; Nathalie Bravenboer; Jenneke Klein-Nulend
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

10.  Exome sequencing and characterization of 49,960 individuals in the UK Biobank.

Authors:  Cristopher V Van Hout; Ioanna Tachmazidou; Joshua D Backman; Joshua D Hoffman; Daren Liu; Ashutosh K Pandey; Claudia Gonzaga-Jauregui; Shareef Khalid; Bin Ye; Nilanjana Banerjee; Alexander H Li; Colm O'Dushlaine; Anthony Marcketta; Jeffrey Staples; Claudia Schurmann; Alicia Hawes; Evan Maxwell; Leland Barnard; Alexander Lopez; John Penn; Lukas Habegger; Andrew L Blumenfeld; Xiaodong Bai; Sean O'Keeffe; Ashish Yadav; Kavita Praveen; Marcus Jones; William J Salerno; Wendy K Chung; Ida Surakka; Cristen J Willer; Kristian Hveem; Joseph B Leader; David J Carey; David H Ledbetter; Lon Cardon; George D Yancopoulos; Aris Economides; Giovanni Coppola; Alan R Shuldiner; Suganthi Balasubramanian; Michael Cantor; Matthew R Nelson; John Whittaker; Jeffrey G Reid; Jonathan Marchini; John D Overton; Robert A Scott; Gonçalo R Abecasis; Laura Yerges-Armstrong; Aris Baras
Journal:  Nature       Date:  2020-10-21       Impact factor: 69.504

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.